Pill may cut HIV risk as much as 99%
Daily use of a pill approved to protect against HIV infection cuts a man's risk of getting the virus by 99%, a new study indicates. The research also offers the first evidence that even imperfect adherence to the treatment regimen can provide a big reduction in the risk of acquiring the virus, which causes AIDS. This article courtesy of the Gladstone Institutes and World Science staff.
Participants in the research were found to be able to cut their HIV infection risk by 76% merely by taking two doses a week.
The study, published in the 12 September online issue of the research journal Science Translational Medicine, examines the effectiveness of a FDA-approved drug known as tenofovir disoproxil fumarate (brand name Truvada). Read the article.
Source: WeCanChangeOurWorld
WeCanChangeOurWorld is an online social network in the sustainable social transformation space in South Africa. Our objectives will be to enable all brands, organisations and practitioners to congregate to create tangible intellectual assets, to share key learnings, ideas and best practice in this vibrant and essential sector for our country's growth and sustainability for all its people. WeCanChangeOurWorld aims to be a change agent for brands serious about sustainable transformation in South Africa. The portal is a platform for all companies and organisations involved in sustainable brand programmes and initiatives to connect with influencers and non-governmental/governmental organisations involved in sustainable social transformation in South Africa.
Go to: http://www.wecanchange.co.za/AboutUs/tabid/66/Default.aspx